Trial Profile
Retrospective cohort study of predictive role of metastatic sites in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors (TKIs)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Sunitinib (Primary) ; Bevacizumab; Interferon alpha; Pazopanib; Temsirolimus
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 16 Dec 2015 New trial record